HCW Biologics (HCWB) Construction in Progress (2023 - 2025)
HCW Biologics' (HCWB) quarterly Construction in Progress came in at $13.5 million in Q4 2025, little changed YoY from $13.5 million in Q4 2024, and little changed on a QoQ basis from $13.5 million in Q4 2024.
HCW Biologics (HCWB) Construction in Progress (2023 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 3 years of Construction in Progress data on file, last reported at $13.5 million in Q4 2025.
- Quarterly Construction in Progress changed 0.0% year-over-year to $13.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $13.5 million, changed 0.0% from the prior year.
- Construction in Progress was little changed at $13.5 million in Q4 2025, from $13.5 million in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $13.5 million in Q4 2024 to a low of $10.4 million in Q4 2023.
- A 3-year average of $12.5 million and a median of $13.5 million in 2024 frame the typical range for Construction in Progress.
- Annual changes were most pronounced in 2024 — Construction in Progress advanced 29.81% — and 2025, when it changed 0.0%.
- Tracing HCWB's Construction in Progress over 3 years: stood at $10.4 million in 2023, then climbed by 29.81% to $13.5 million in 2024, then changed by 0.0% to $13.5 million in 2025.
- The last three Construction in Progress figures came in at $13.5 million (Q4 2025), $13.5 million (Q4 2024), and $10.4 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 152.67 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.50 Mn |
| Dec 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 10.40 Mn |